These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11685267)

  • 21. Signs of an in situ inflammatory reaction in scars of human American tegumentary leishmaniasis.
    Morgado FN; Schubach A; Vasconcellos E; Azeredo-Coutinho RB; Valete-Rosalino CM; Quintella LP; Santos G; Salgueiro M; Palmeiro MR; Conceição-Silva F
    Parasite Immunol; 2010 Apr; 32(4):285-95. PubMed ID: 20398229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmaniasis recidiva cutis in American cutaneous leishmaniasis.
    Bittencourt AL; Costa JM; Carvalho EM; Barral A
    Int J Dermatol; 1993 Nov; 32(11):802-5. PubMed ID: 8270337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of polymerase chain reaction to confirm diagnosis in skin biopsies consistent with American tegumentary leishmaniasis at histopathology: a study of 90 cases.
    Andrade RV; Massone C; Lucena MN; Talhari AC; Talhari S; Guerra JA; Ferreira LC
    An Bras Dermatol; 2011; 86(5):892-6. PubMed ID: 22147028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis.
    Barral A; Guerreiro J; Bomfim G; Correia D; Barral-Netto M; Carvalho EM
    Am J Trop Med Hyg; 1995 Sep; 53(3):256-9. PubMed ID: 7573708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of immunoglobin isotype specific to Leishmania in tegumentary American leishmaniasis].
    Labrada M; Weigle K; Valderrama L; Saravia NG
    Mem Inst Oswaldo Cruz; 1989; 84(3):409-16. PubMed ID: 2520833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of an immunoenzymatic test for detection of anti-L. brasiliensis antibodies compared to other tests used for the diagnosis of American cutaneous leishmaniasis.
    Ferreira MP; Roselino AM; Nascimento MM; Aires JM; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2006; 48(4):215-7. PubMed ID: 17119678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis.
    Carvalho EM; Correia Filho D; Bacellar O; Almeida RP; Lessa H; Rocha H
    Am J Trop Med Hyg; 1995 Sep; 53(3):273-7. PubMed ID: 7573712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in anti-Leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure.
    Fagundes-Silva GA; Vieira-Goncalves R; Nepomuceno MP; de Souza MA; Favoreto S; Oliveira-Neto MP; Da-Cruz AM; Gomes-Silva A
    Parasite Immunol; 2012 Oct; 34(10):486-91. PubMed ID: 22742527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoperoxidase technique using an anti-Leishmania (L.) chagasi hyperimmune serum in the diagnosis of culture-confirmed American tegumentary leishmaniasis.
    Quintella LP; Cuzzi T; Madeira Mde F; Okamoto T; Schubach Ade O
    Rev Inst Med Trop Sao Paulo; 2009; 51(2):83-6. PubMed ID: 19390736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay in patients from Northern Paraná State, Brazil.
    Yoneyama KA; de Peder LD; Lonardoni MV; Silveira TG
    Braz J Infect Dis; 2007 Jun; 11(3):360-4. PubMed ID: 17684640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis.
    Sousa-Atta ML; Salamé GS; D'Oliveira A; Almeida RP; Atta AM; Carvalho EM
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):101-4. PubMed ID: 11777837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Performance analysis of the research of IgG antibodies alive promastigote anti-forms of Leishmania (V.) braziliensis (AAPV-IgG), for flow cytometry in the diagnosis of the leishmaniasis american tegumentar].
    Rocha RD; Gontijo CM; Santos SM; Carvalho AT; Ferrari TC; Oliveira RC; Marques MJ; Mayrink W; Martins-Filho OA
    Rev Soc Bras Med Trop; 2003; 36 Suppl 2():15-8. PubMed ID: 15719766
    [No Abstract]   [Full Text] [Related]  

  • 35. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection.
    Gomes-Silva A; Valverde JG; Ribeiro-Romão RP; Plácido-Pereira RM; Da-Cruz AM
    Parasitology; 2013 May; 140(6):771-9. PubMed ID: 23369503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis.
    Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira-Carvalho A; Corrêa-Oliveira R; Ferrari TC; Marques MJ; Mayrink W; Martins-Filho OA
    Trop Med Int Health; 2006 Feb; 11(2):156-66. PubMed ID: 16451339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.
    Gomes AHS; Martines RB; Kanamura CT; Barbo MLP; Iglezias SD; Lauletta Lindoso JA; Pereira-Chioccola VL
    Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28239875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.
    Souza MA; Almeida TM; Castro MC; Oliveira-Mendes AP; Almeida AF; Oliveira BC; Rocha LF; Medeiros AC; Brito ME; Dessein AJ; Pereira VR
    Immunobiology; 2016 Feb; 221(2):253-9. PubMed ID: 26572279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-live Leishmania (Viannia) braziliensis promastigote antibodies, detected by flow cytometry, to identify active infection in american cutaneous leishmaniasis].
    Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira Carvalho A; Corrêa-Oliveira R; Marques MJ; Genaro O; Mayrink W; Martins-Filho OA
    Rev Soc Bras Med Trop; 2002; 35(6):551-62. PubMed ID: 12612734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.